Sirtex Announces FOXFIRE and FOXFIRE Global Studies
Published date : 01 April 2015
Article date : 01 April 2015
Sirtex Medical Limited has announced it completed patient enrolment in FOXFIRE and FOXFIRE Global, two large-scale multi-centre clinical trials that combine liver-directed radiation therapy with SIR-Spheres Y-90 resin microspheres to a chemotherapy regimen in over 560 inoperable metastatic colorectal cancer (mCRC) patients.
Source http://radiationtherapynews.com/